Molecular Biologist Expert in Clinical Diagnostic Research and Development, CLIA Compliance, DNA Repair and Oncology

Technical Consultant #1952


  • Clinical diagnostic research and development, oncology, gene therapy and editing, translational medicine, and industrial microbiology.
  • DNA repair, gene therapy, gene repair and editing.
  • Oncology research, including small molecule aptamers and translational medicine.
  • Industrial microbiology and synthetic biology strain engineering to improve peptide production in E. coli.
  • CLIA accreditation and compliance for clinical diagnostic laboratories.
  • Collaboration with physicians and researchers to explore and market new diagnostic opportunities.
  • Management experience with research and laboratory operations.
  • Next generation sequencing (NGS) technology experience for genome, exome, RNA-sequencing.
  • Clinical diagnostic assay research for Borrelia burgdorferi, Lyme disease.
  • Expert Panelist with the Rare Genomics Institute, which helps patients with orphan diseases initiate and fund personalized research projects through a dedicated microfunding platform and highly-selective network of leading academic scientists and commercial institutions.


Undisclosed Company, Chief Operating Officer, 2012 - Present

  • Next generation sequencing (NGS) technology for genome, exome, RNA, and a variety of clinical disease panels.
  • Development of commercialization of large-scale genetic diagnostic information in a disease-specific manner (e.g., deafness-causing, cancer-related, for both research and clinical purposes.

Rare Genomics Institute, St. Louis, MO, Expert Panelist, 2012 - Present

  • Assist patients with orphan diseases initiate and fund personalized research projects through a dedicated microfunding platform and highly-selective network of leading academic scientists and commercial institutions.

Advanced Laboratory Services, Sharon Hill, PA, Associate Director, 2011 - 2012

  • Participate in the daily operations of a medium to high complexity clinical diagnostic laboratory.
  • Developing new-to-market diagnostics while providing high quality services for our clients and their patients.
  • Contribute to research, development, sample processing, marketing, and management of 12-member clinical and research team.

E.I. DuPont de Nemours & Co., Wilmington, DE, Molecular Biologist, 2008 - 2011

  • Central Research & Development (CRD).
  • Biochemical Science and Engineering (BCSE).
  • Strain engineering to improve peptide production in E. coli strains.
  • Identify traits beneficial for project goals in fermentation.

University of Delaware, Newark, DE, Doctoral Candidate, 2002 - 2008

  • Targeted gene repair in mammalian cells using single-stranded DNA oligonucleotides in an applied genomic laboratory.
  • Novel use of single-stranded DNA oligonucleotides to selectively kill tumor cells.
  • Research Assistantship: Delaware Center for Translational Cancer Research.

Johns Hopkins University, Bloomberg School of Public Health, Baltimore, MD, 2000 - 2002

  • Senior Laboratory Technician, Molecular Microbiology and Immunology Laboratory
  • Studied the genetic diversity of Borrelia burgdorferi, and abiotic and biotic factors effecting the life cycle of Borrelia.

Honors & Publications

Academic and Professional Affiliations

  • American Association of Cancer Research (AACR)
  • American Society of Human Genetics (ASHG)


  • Gettysburg College, Deans Honor List and Deans Commendation List

Publications and Patents

Author and Co-Author of numerous publications in peer reviewed journals - subject matters:

  • Polypeptide self-assembly enhances its expression, processing, and function in a Bionanotechnology application.
  • Using bleomycin to stimulate targeted gene repair activity in mammalian cells.
  • A specific guanosine-rich oligonucleotide, capable of forming stable quadruplex structures selectively blocks proliferation and induces apoptosis in esophageal tumor cells.
  • Single-strand DNA Oligonucleotides increase sensitivity of cancer cells to chemotherapeutic agents.
  • Mammal Diversity and Infection Prevalence in the Maintenance of Enzootic Lyme Disease.
  • Spotted-fever group Rickettsia in Dermacentor variabilis.
  • DNA damage and homologous recombination regulate the frequency and process of targeted gene repair.
  • Abiotic and biotic factors affecting the enzootic cycle of Lyme disease.
  • Environmental factors contributing to the prevalence of Lyme disease in the white-footed mouse populations.
  • 2 U.S. Patents.


  • Ph.D. Biology, University of Delaware, Newark, DE
  • B.S. Biology, Gettysburg College, Gettysburg, PA
Save Resume #1952
to Contact Form?

You must first click "Yes" to save this resume

Submit Request

You have no Saved Resumes

Add resumes within our various Ares of Expertise by clicking "Add Resume(s)" below.

Add Resume(s)